Others

Glaxosmithkline Consumer Healthcare Ltd. - Advance Intimation Under Regulation 39(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

| Updated on February 15, 2019 Published on February 15, 2019

Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), we would like to inform you that Registrar and Transfer Agent of Company M/s. Karvy Fintech Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholder:

Sr.
No. Name Folio no. Certificate no. Number of Shares Distinctive No. From Distinctive No. To
1. Shobha Ramakant Kamat,
Veena Ramakant Kamat and
Sunanda Ramakant Kamat S02338 48340
231825-231826
411151- 411153 232 4999086
27379477
44217060 4999097
27379576
44217179
2. Yazdi Nariman Batliwala and
Pervin Nariman Batliwala Y00289 27083
52603
78454
119832 100 3424545
5143273
7070370
7070370 3424569
5143284
7070382
14150479


We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company

Kindly take the same on record.

Pdf Link: Glaxosmithkline Consumer Healthcare Ltd. - Advance Intimation Under Regulation 39(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Source : BSE - www.bseindia.com

Published on February 15, 2019
This article is closed for comments.
Please Email the Editor